XY Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-59,048
Closed -$2.83M – 83
2026
Q2
$2.83M Buy
+59,048
New +$2.54M 2.73% 12
2023
Q2
– Sell
-4,308
Closed -$343K – 133
2023
Q1
$343K Buy
+4,308
New +$305K 0.13% 84

Other funds holding NVO

XY Capital's NVO Position: Q3 2026 in Review

XY Capital sold out of Novo Nordisk (NVO) in Q3 2026, closing a stake of 59,048 shares — an estimated $2.83M sold.

XY Capital first reported a position in NVO in Q1 2023 and held it in 2 quarters. The position peaked at $2.83M in Q2 2026. 1,235 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • XY Capital reported no remaining Novo Nordisk position as of Q3 2026 after selling out during the quarter.
  • XY Capital sold 59,048 Novo Nordisk shares in Q3 2026, an estimated $2.83M.
  • XY Capital first reported a position in Novo Nordisk in Q1 2023 and held it in 2 quarters.
  • XY Capital's Novo Nordisk position peaked at $2.83M in Q2 2026.
  • 1,235 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on XY Capital's 13F filing for Q3 2026, filed 13 Nov 2026.